Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccrol Gp Regulatory News (ACRL)

Share Price Information for Accrol Gp (ACRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 38.60
Bid: 38.60
Ask: 38.80
Change: 0.00 (0.00%)
Spread: 0.20 (0.518%)
Open: 38.70
High: 38.70
Low: 38.60
Prev. Close: 38.60
ACRL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Senior Management Change

10 Apr 2019 07:00

RNS Number : 6771V
Accrol Group Holdings PLC
10 April 2019
 

 

10 April 2019

 

Accrol Group Holdings plc

("Accrol" or the "Group")

 

Senior Management Change: Appointment of Group Finance Director

 

Accrol, the UK's leading independent tissue converter, is pleased to announce that John Pilkington has accepted the permanent role of Group Finance Director with immediate effect.

 

John joined the senior management team of Accrol in September 2018, as Group Financial Controller. Since then, he has gained a strong understanding of the business and its financials and has been closely involved in the latter stages of the turnaround process.

 

John qualified as a Chartered Accountant with KPMG and has nearly 20 years' experience as a senior finance executive, including over 10 years with Promethean World Limited (formerly Promethean World Plc), latterly as Group Financial Controller.

 

Hannah Argo, who was appointed Interim Chief Financial Officer whilst a search for a permanent replacement was undertaken, has completed her contract and leaves the Company today.

 

Dan Wright, Executive Chairman of Accrol, said: "We are delighted that John has accepted the role of permanent Group Finance Director. His knowledge and understanding of the Group, gained during an intense and difficult period for the Group, will allow him to hit the ground running. The Board has been thoroughly impressed with his contribution and commitment to the business over the last seven months and we look forward to working with him even more closely."

 

"On behalf of all the directors, I thank Hannah for stepping into the role of Interim CFO and for her work during this time."

The Board remains unchanged, comprising Dan Wright (Executive Chairman), Gareth Jenkins (Chief Executive Officer), Euan Hamilton (Non-Executive) and Simon Allport (Non-Executive).

 

For further information, please contact:

 

 

 

Accrol Group Holdings plc

 

Dan Wright, Executive Chairman

Tel: +44 (0) 1254 278 844

Gareth Jenkins, Chief Executive Officer

 

 

 

Zeus Capital Limited (Nominated Adviser & Broker) 

 

Dan Bate / Andrew Jones

Tel: +44 (0) 161 831 1512

Dominic King / John Goold

Tel: +44 (0) 203 829 5000

 

 

Belvedere Communications Limited

 

Cat Valentine (cvalentine@belvederepr.com)

Tel: +44 (0) 7715 769 078

Keeley Clarke (kclarke@belvederepr.com)

Tel: +44 (0) 7967 816 525

Llew Angus (langus@belvederpr.com)

Tel: +44 (0)7407 023 147

 

Notes to Editors

 

Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues, as well as other tissue products, to major discounters and grocery retailers throughout the UK. Accrol operates from three sites:

 

·

A manufacturing, storage and distribution facility in Blackburn;

·

A facial tissue plant, also in Blackburn; and

·

A manufacturing, storage and distribution facility in Leyland.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOALLFIRSDIAIIA
Date   Source Headline
28th Mar 20241:14 pmPRNForm 8.3 - Accrol Group Holdings plc
28th Mar 202410:32 amRNSForm 8.3 - Accrol Group Holdings Plc
28th Mar 20249:11 amRNSTR-1
28th Mar 20248:15 amGNWForm 8.5 (EPT/RI) - Accrol Group Holdings Plc
27th Mar 20243:01 pmPRNForm 8.3 - Accrol Group Holdings PLC
27th Mar 20242:34 pmRNSForm 8.3 - Accrol Group Holding PLC
27th Mar 20242:28 pmRNSForm 8.3 - Accrol Group Holdings plc
27th Mar 20242:26 pmPRNForm 8.3 - ACCROL GROUP HOLDINGS PLC
27th Mar 20242:06 pmRNSForm 8.3 - Accrol Group Holdings Plc
27th Mar 202412:42 pmPRNForm 8.3 - Accrol Group Holdings plc
27th Mar 202412:26 pmRNSForm 8.3 - Accrol Group Holdings Plc
27th Mar 20247:26 amGNWForm 8.5 (EPT/RI) - Accrol Group Holdings Plc
26th Mar 20243:33 pmRNSTR-1
26th Mar 20241:57 pmPRNForm 8.3 - Accrol Group Holdings plc
26th Mar 20241:01 pmRNSForm 8.3 - Accrol Group Holdings Plc
26th Mar 202412:57 pmRNSForm 8.3 - Accrol Group Holdings PLC
26th Mar 202412:00 pmRNSForm 8.3 - Accrol Group Holdings plc
26th Mar 202411:51 amPRNForm 8.3 - Accrol Group Holdings PLC
26th Mar 202410:02 amPRNForm 8.3 - Accrol Group Holdings plc
26th Mar 20249:17 amGNWForm 8.5 (EPT/RI) - Accrol Group Holdings Plc
25th Mar 20245:09 pmPRNForm 8.3 - Accrol Group Holdings PLC
25th Mar 20245:03 pmPRNForm 8.3 - Accrol Group Holdings Plc
25th Mar 20243:08 pmRNSForm 8.3 - ACCROL GROUP HOLDINGS PLC
25th Mar 20242:31 pmRNSForm 8.3 - Accrol Group Holdings
25th Mar 20242:19 pmRNSForm 8.3 - Accrol Group Holdings Plc
25th Mar 20241:33 pmPRNForm 8.3 - Accrol Group Holdings plc
25th Mar 202411:52 amRNSForm 8.3 - Accrol Group Holdings PLC
25th Mar 202411:00 amPRNForm 8.3 - Accrol Group Holdings plc
25th Mar 202410:51 amRNSForm 8 (DD) - Accrol Group Holdings PLC
25th Mar 202410:24 amRNSForm 8.3 - Accrol Group Holdings PLC
25th Mar 20247:59 amGNWForm 8.5 (EPT/RI) - Accrol Group Holdings Plc
22nd Mar 20241:24 pmPRNForm 8.3 - Accrol Group Holdings plc
22nd Mar 202412:28 pmRNSForm 8.3 -Accrol Group Holdings PLC
22nd Mar 20248:17 amRNSForm 8.3 - Accrol Group Holdings plc
22nd Mar 20247:00 amRNSRecommended Cash Offer
1st Mar 20243:52 pmRNSTR-1
8th Feb 20247:00 amRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSTR-1
30th Jan 20247:00 amRNSHalf Year Results
26th Jan 20247:00 amRNSNotice of Results and Investor Webinar
19th Jan 20247:00 amRNSTR-1
18th Jan 20247:00 amRNSAcquisition of Severn Delta Limited
22nd Nov 20237:00 amRNSHalf Year Trading Update
24th Oct 20232:37 pmRNSResult of AGM
18th Oct 202311:52 amRNSTR-1
18th Oct 202311:49 amRNSTR-1
17th Oct 20235:40 pmRNSTR-1
28th Sep 20239:47 amRNSNotice of AGM and Posting of Annual Report 2023
26th Sep 20237:00 amRNSFinal Results 2023
22nd Sep 20237:00 amRNSNotice of Results and Online Presentations

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.